Searched for
SANJEEV I DANI
Stocks in news: Airtel, Titan, Maruti Suzuki, BPCL, TCS, WiproAdani Enterprises arm Adani Defence Systems has signed a shareholders agreement and share subscription agreement with Elbit Systems, Israel.- Kotak Group, Screwvala’s USports buy teams in Ultimate Table TennisThe Kotak Group’s Insurekot Sports, which also runs Pro Kabaddi franchisee Puneri Paltan, will own the team.
- Sensex, Nifty rangebound ahead of F&O expiry; top 10 stocks in focusSensex was trading in a range on Thursday ahead of November month F&O expiry due today, led by losses in ITC, Tata Motors, ONGC and HDFC.
- Ten stocks in focus in Thursday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
- Ranbaxy inks pact with Cipher to sell acne drug in BrazilRanbaxy has inked a licensing pact with Cipher Pharmaceuticals Inc to exclusively market its isotretinoin capsules, used to treat acne, in ...
- Ranbaxy enters into licensing pact with EPIRUS SwitzerlandRanbaxy Laboratories have entered into a licensing pact with EPIRUS Switzerland GmbH for treating rheumatoid arthiritis.
- Ranbaxy sells Vietnam biz, to exit another in growth bidRanbaxy Laboratories, India’s largest pharma company, has sold its Vietnam business and is also looking to divest another, as part of a rat...
- Ranbaxy strengthens presence in the Middle-EastRanbaxy Laboratories has commenced Yemen operations in collaboration with local co Pharma Ltd, strengthening its presence in the Middle-Eas...
- Ranbaxy launches Bio-generic injectable for OsteoporosisRanbaxy Laboratories Ltd on Thursday announced the launch of 'BONISTA- Teriparatide' injection used in the treatment of Osteoporosis diseas...
- Ranbaxy to introduce INERSAN brand in India and NepalCountry's largest drug maker Ranbaxy Laboratories said it has entered into an agreement with CD Pharma to market its drug INERSAN, used for...
- Ranbaxy Labs enters deal CD Pharma to market INERSANRanbaxy Laboratories has entered into an exclusive in-licensing agreement with CD Pharma to market the INERSAN brand in India and Nepal.
- Ranbaxy launches osonase nasal sprayAllergic rhinitis affects 10-25 per cent of the global population and is believed to be a precursor for Asthma, Ranbaxy said.
- Ranbaxy launches osonase nasal sprayRanbaxy Laboratories Ltd on Wednesday launched its a nasal spray Osonase (Ciclesonide) aqueous in India used in the treatment of perennial ...
- Ranbaxy launches new drug for asthmaRanbaxy Laboratories Ltd on Tuesday announced the launch of its branded product, Avessa inhalation capsules in India for the treatment of A...
Load More
